12.10.2017
- US drugmaker Merck has agreed to pay KalVista Pharmaceuticals more than $750 million to gain the rights to KVD001, an investigational treatment for diabetic macular edema (DME), as...
14.09.2017
- US drugmaker Merck has announced plans to acquire Germany-based Rigontec, regarded as a pioneer in accessing the retinoic acid-inducible gene I (RIG-I) pathway as a novel and...
17.08.2017
- US President Donald Trump disbanded his US Manufacturing Council on Aug. 16, a day after the exodus of US Merck’s CEO Kenneth Frazier in protest over remarks made by the president...
11.08.2017
- Sanofi has sued US Merck, alleging infringement of two patents related to an insulin drug. The French drugmaker said the action was triggered by a notification received from Merck...
04.08.2017
- French drugmaker Sanofi has signed a research and licensing deal with Belgian biopharmaceutical company Ablynx, initially focusing on the development and commercialization of...
01.08.2017
- AstraZeneca has entered into a global collaboration with US drugmaker Merck to develop and commercialize the former’s investigational cancer treatments Lynparza (olaparib) and...
26.07.2017
- US Merck’s shingles (herpes zoster) vaccine Zostavax continues to be the target of legal action at a time when the drugmaker is already facing the prospect of competition from...
12.07.2017
- The US Food and Drug Administration (FDA) has placed a clinical hold on three phase 3 multiple myeloma studies testing US drugmaker Merck’s Keytruda (pembrolizumab) in combination...
